Treatment of Early-Stage Hypopharyngeal by Radiation Therapy

  • Shelley Hukku
  • Shikha Halder
  • Bidhu K. Mohanti


Cancers arising from the hypopharynx are more commonly seen in developing countries including India, compared to the western countries. Out of all head and neck cancers (HNC), the reported incidence rates are 2–5% in the developed versus 15–30% in the developing countries [1]. In view of its anatomic location, the hypopharynx is a blind spot in the head and neck region of the human body. Unless the patient has serious compromise in the food swallowing activity, a gross change in voice or both, he/she does not report. Hence, more than 70% are diagnosed at an advanced stage, and the early stages I–II are reported in approximately 25% of all hypopharyngeal cancers [2]. Majority of these cancers arise from the pyriform sinus (PFS), whereas post-cricoid cancer is common in an anaemic female. Squamous cell carcinoma is the commonest histologic type. In India, hypopharyngeal cancers constitute more than 10% of all HNC [3].


  1. 1.
    Gupta T, Chopra S, Agarwal JP, Laskar SG, D’cruz AK, Shrivastava SK, Dinshaw KA. Squamous cell carcinoma of the hypopharynx: single-institution outcome analysis of a large cohort of patients treated with primary non-surgical approaches. Acta Oncol. 2009;48:541–8.CrossRefGoogle Scholar
  2. 2.
    Petersen JF, Timmermans AJ, van Dijk BAC, et al. Trends in treatment, incidence and survival of hypopharynx cancer: a 20-year population-based study in the Netherlands. Eur Arch Otorhinolaryngol. 2018;275:181–9.CrossRefGoogle Scholar
  3. 3.
    Mohanti BK, Nachiappan P, Pandey RM, Sharma A, Bahadur S, Thakar A. Analysis of 2167 head and neck cancer patients’ management, treatment compliance and outcomes from a regional cancer centre, Delhi, India. J Laryngol Otol. 2007;121:49–56.CrossRefGoogle Scholar
  4. 4.
    Pracy P, Loughran S, Good J, Parmar S, Goranova R. Hypopharyngeal cancer: United Kingdom national multidisciplinary guidelines. J Laryngol Otol. 2016;130(S2):S104–10.CrossRefGoogle Scholar
  5. 5.
    Bok GH, Cho WY, Cho JY, Jin SY, Ahn JH, Chun CG, Lee TH, Kim HG. Endoscopic resection of hypopharyngeal squamous cell carcinoma. Clin Endosc. 2013;46:189–92.CrossRefGoogle Scholar
  6. 6.
    Imanishi Y, Ozawa H, Sakamoto K, Fujii R, Shigetomi S, Habu N, Otsuka K, Sato Y, Watanabe Y, Sekimizu M, Ito F, Tomita T, Ogawa K. Clinical outcomes of transoral videolaryngoscopic surgery for hypopharyngeal and supraglottic cancer. BMC Cancer. 2017;17:445.CrossRefGoogle Scholar
  7. 7.
    Hall SF, Groome PA, Irish J, O’Sullivan B. Radiotherapy or surgery for head and neck squamous cell cancer: establishing the baseline for hypopharyngeal carcinoma? Cancer. 2009;115:5711–22.CrossRefGoogle Scholar
  8. 8.
    Nishimura H, Sasaki R, Yoshida K, Miyawaki D, Okamoto Y, Kiyota N, Saito M, Otsuki N, Nibu K. Radiotherapy for stage I or II hypopharyngeal carcinoma. J Radiat Res. 2012;53:892–9.CrossRefGoogle Scholar
  9. 9.
    Kawashima M, Hayashi R, Tahara M, Yamazaki M, Miyazaki M, Arahira S, Ogino T. Accelerated radiotherapy and larynx preservation in favorable-risk patients with T2 or worse hypopharyngeal cancer. Jpn J Clin Oncol. 2007;37:345–52.CrossRefGoogle Scholar
  10. 10.
    Boyer A, Biggs P, Galvin J, et al. Basic applications of multileaf collimators.AAPM Report No.72. Wisconsins: Medical Physics Publishing; 2001.Google Scholar
  11. 11.
    Studer G, Peponi E, Kloeck S, Dossenbach T, Huber G, Glanzmann C. Surviving hypopharynx-larynx carcinoma in the era of IMRT. Int J Radiat Oncol Biol Phys. 2010;77:1391–6.CrossRefGoogle Scholar
  12. 12.
    Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys. 2008;35:310–7.CrossRefGoogle Scholar
  13. 13.
    Holt A, Van Gestel D, Arends MP, et al. Multi-institutional comparison of volumetric modulated arc therapy vs. intensity-modulated radiation therapy for head-and-neck cancer: a planning study. Radiat Oncol. 2013;8:26. Scholar
  14. 14.
    Amdur RJ, Mendenhall WM, Stringer SP, Villaret DB, Cassisi NJ. Organ preservation with radiotherapy for T1-T2 carcinoma of the pyriform sinus. Head Neck. 2001;23:353–62.CrossRefGoogle Scholar
  15. 15.
    Nakajima A, Nishiyama K, Morimoto M, Nakamura S, Suzuki O, Kawaguchi Y, Miyagi K, Fujii T, Yoshino K. Definitive radiotherapy for T1-2 hypopharyngeal cancer: a single-institution experience. Int J Radiat Oncol Biol Phys. 2012;82:e129–35.CrossRefGoogle Scholar

Copyright information

© The Author(s) 2019

Authors and Affiliations

  • Shelley Hukku
    • 1
  • Shikha Halder
    • 1
  • Bidhu K. Mohanti
    • 2
  1. 1.Department of Radiation OncologyBLK Super Specialty HospitalNew DelhiIndia
  2. 2.Department of Radiation OncologyManipal HospitalNew DelhiIndia

Personalised recommendations